Abstract
Currently, choosing the correct surgical tactic for metastases of well-differentiated thyroid cancer is one of the major problems in endocrine surgery. In most cases, early detection of metastases and their timely surgical removal can prevent the dissemination of the disease. Aim of the research is to assess the behavior and the significance of lymphogenic metastasis of thyroid cancer, to determine the optimal approaches to the treatment of locoregional metastases. Material and Methods. Patients were operated and observed in the Department of Surgery of the Endocrine Glands of The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism of the NAMS of Ukraine» for the period from 1990 to 2021. Results. Large dissections needed for metastases in the lateral lymphatic nodes (LN) of a neck are associated with the possibility of damaging the nerves (accessory nerve, marginal mandibular nerve, sympathetic nerve, phrenic nerve, vagus nerve, hypoglossal nerve, brachial nerve), risk of bleeding and lymphorrhea, esthetical problems (longer dissection). Complications of lateral neck dissections can reach 50%, lymphorrhea — up to 3.6%, chronic neck pain and numbness — 11% [13]. Some studies show that additional lateral dissection of the neck during surgery on the central cervical spine region doubles the risk of transient hypoparathyroidism. Conclusions. With thyroid carcinomas (TC) preventive central neck dissection should be performed for patients of intermediate and high-risk groups. With small non-invasive papillary TC preventive central neck dissection may not be performed. Suspicious lateral LN of the neck should be examined by the fine-needle aspiration biopsy of the thyroid under ultrasound control to confirm the lateral lesion of the neck, and if there are indications the complex therapeutic neck dissection should be performed at levels IIa, III, IV, and Vb. The absence of signs of metastatic lesions of the LN I or IIb compartments of the neck makes it possible not to perform their routine dissection and this reduces the risk of damage to the accessory nerve.
References
Fritze D, Doherty GM. Surgical management of cervical lymph nodes in differentiated thyroid cancer. Otolaryngol Clin North Am. 2010 Apr;43(2):285-300, viii. doi: 10.1016/j.otc.2010.01.005.
Dionigi G, Dionigi R, Bartalena L, Boni L, Rovera F, Villa F. Surgery of lymph nodes in papillary thyroid cancer. Expert Rev Anticancer Ther. 2006 Sep;6(9):1217-29. doi: 10.1586/14737140.6.9.1217.
Stack BC Jr, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S, et al; American Thyroid Association Surgical Affairs Committee. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012 May;22(5):501-8. doi: 10.1089/thy.2011.0312.
Randle RW, Pitt SC. The role of node dissection for thyroid cancer. Adv Surg. 2021 Sep;55:131-45. doi: 10.1016/j.yasu.2021.05.010.
Sancho JJ, Lennard TW, Paunovic I, Triponez F, Sitges-Serra A. Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2014 Feb;399(2):155-63. doi: 10.1007/s00423-013-1152-8.
Sturgeon C, Yang A, Elaraj D. Surgical management of lymph node compartments in papillary thyroid cancer. Surg Oncol Clin N Am. 2016 Jan;25(1):17-40. doi: 10.1016/j.soc.2015.08.013.
Dy BM, Shaha AR. Philosophy on neck dissection in thyroid cancer-current controversies and consensus. Indian J Surg Oncol. 2018 Mar;9(1):2-5. doi: 10.1007/s13193-017-0720-8.
Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A, et al; American Thyroid Association Surgical Affairs Committee Writing Task Force. Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid. 2015 Jan;25(1):15-27. doi: 10.1089/thy.2014.0098.
American Thyroid Association Surgery Working Group; American Association of Endocrine Surgeons; American Academy of Otolaryngology-Head and Neck Surgery; American Head and Neck Society, Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009 Nov;19(11):1153-8. doi: 10.1089/thy.2009.0159.
Musholt TJ. Classification of locoregional lymph nodes in medullary and papillary thyroid cancer. Langenbecks Arch Surg. 2014 Feb;399(2):217-23. doi: 10.1007/s00423-013-1146-6.
Agrawal N, Evasovich MR, Kandil E, Noureldine SI, Felger EA, Tufano RP, et al. Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement. Head Neck. 2017 Jul;39(7):1269-79. doi: 10.1002/hed.24715.
Nixon IJ, Shaha AR. Management of regional nodes in thyroid cancer. Oral Oncol. 2013 Jul;49(7):671-5. doi: 10.1016/j. oraloncology.2013.03.441.
Scharpf J, Tuttle M, Wong R, Ridge D, Smith R, Hartl D, et al. Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement: AHNS consensus statement. Head Neck. 2016 Dec;38(12):1862-9. doi: 10.1002/hed.24513.
